A diabetes patient has filed an Invokana lawsuit against drug company Janssen Pharmaceuticals, alleging his Invokana adverse effects included a series of lower extremity amputations.

The Invokana adverse effects lawsuit was filed joining a growing multidistrict litigation against the company in New Jersey federal court.

Plaintiff Leon S. filed the lawsuit on Feb. 28, 2018. According to the Invokana adverse effects lawsuit, Leon, a citizen and resident for the state of Tennessee, says that he began taking Invokana after being prescribed it by his physician for treatment of his type-2 diabetes. He maintains that he relied on the drug company’s assurances that the medication was safe and effective for use.

However, after taking Invokana, Leon says he underwent two successive amputations of his right toe, followed by a below the knee amputation of his right leg and an amputation of his left great toe.

According to the lawsuit, his “injuries [were] preventable and resulted directly from [Janssen’s] failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions, and willful misrepresentations concerning the nature and safety of Invokana,” the lawsuit states.

Leon says that he suffered damages including economic loss, loss of enjoyment of life, pain and suffering, emotional distress, and must pay significant expenses for medical care and treatment. Leon is also seeking compensatory, punitive, and actual damages from Janssen Pharmaceuticals.

The Invokana adverse effects lawsuit was filed on multiple counts including manufacturing defect, defective design, failure to warn, breach of express warranty, breach of warranty of fitness for ordinary use, negligence, breach of implied warranty, fraudulent misrepresentation, negligent misrepresentation, fraudulent concealment, fraud, and punitive damages.

Leon demands a trial by jury.

Invokana Adverse Effects

Invokana (canagliflozin) is a diabetes medication manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Soon after its introduction to the drug market in 2013, it quickly saw a rise in popularity, partly due to an aggressive marketing campaign led by its manufacturers.

Invokana is grouped into a class of medications known as sodium-glucose co transporter 2 medications (SGLT-2). The group of drugs was approved by the U.S. Food and Drug Administration (FDA) to help treat type-2 diabetes.

There have been a multitude of Invokana adverse side effects, however, reported in conjunction with this medication. Some of these adverse side effects include kidney injuries, ketoacidosis, and even bone fractures. The FDA has also continued to receive a multitude of adverse event reports because of serious injuries associated with Invokana.

Side effects linked to Invokana have included some of the following:
• Amputation Risks
• Diabetic Ketoacidosis (DKA)
• Lactic Acidosis
• Kidney and Blood Infections
• Acute Kidney Injury Warning

Though the filing of an Invokana adverse effects lawsuit cannot necessarily remove severe complications suffered with taking Invokana, filing a claim may help individuals with damages such as increased medical expenses, financial compensation, and lost wages.

The Invokana Adverse Effects Lawsuit is Case No. 3:18-cv-02892-BRM-LHG, in the U.S. District Court for the District of New Jersey. The Invokana Lawsuit is MDL No. 2750 is in re: Invokana (Canagliflozin) Products Liability Litigation, in the U.S. District Court for the District of New Jersey.